Neurocrine Biosciences (NBIX) EBIT (2010 - 2026)
Neurocrine Biosciences (NBIX) recorded EBIT of $151.5 million in Q2 2026, up 4.1% from $145.6 million a year earlier but down 21.7% from the prior quarter.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) EBIT (2010 - 2026) Analysis & Trends
On a TTM basis, Neurocrine Biosciences' EBIT came in at $794.8 million as of Jun 30, 2026, up 60.6% year-over-year; for FY2025, it came in at $619.1 million, up 8.5% from FY2024.
- Annual EBIT has increased for four straight years, with a five-year compound annual growth rate of 30.6% (FY2020 to FY2025).
- Across earlier years, EBIT came in at $570.5 million in FY2024 (+127.4%), $250.9 million in FY2023 (+0.8%), $249 million in FY2022 (+142.9%) and $102.5 million in FY2021 (-37.1%).
- Quarterly EBIT has ranged from -$114.2 million in Q1 2023 to $239 million in Q3 2025 over the past five years.
- On a year-over-year basis, EBIT has increased for five consecutive quarters, with growth averaging 93.8% over the last eight quarters.
- Peak year-over-year performance for EBIT in the last five years was growth of 719.5% in Q1 2026, against a decline of 90.2% in Q1 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $193.4 million (Q1 2026), $210.9 million (Q4 2025) and $239 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Neurocrine Biosciences | 14.41 Bn | 10.11 Bn | 935.80 Mn | 151.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 151.50 Mn |
| Mar 31, 2026 | 193.40 Mn |
| Dec 31, 2025 | 210.90 Mn |
| Sep 30, 2025 | 239.00 Mn |
| Jun 30, 2025 | 145.60 Mn |
| Mar 31, 2025 | 23.60 Mn |
| Dec 31, 2024 | 142.00 Mn |
| Sep 30, 2024 | 183.80 Mn |
| Jun 30, 2024 | 145.40 Mn |
| Mar 31, 2024 | 99.30 Mn |
| Dec 31, 2023 | 150.30 Mn |
| Sep 30, 2023 | 141.20 Mn |
| Jun 30, 2023 | 73.60 Mn |
| Mar 31, 2023 | -114.20 Mn |
| Dec 31, 2022 | 103.40 Mn |
| Sep 30, 2022 | 87.80 Mn |
| Jun 30, 2022 | 54.70 Mn |
| Mar 31, 2022 | 3.10 Mn |
| Dec 31, 2021 | -36.30 Mn |
| Sep 30, 2021 | 44.50 Mn |
API Access
Neurocrine Biosciences EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();